Key result
Cardiovascular biomarkers require ongoing evaluation and future development to better address the significant global health burden and mortality of cardiovascular disease.
Key points are not available for this paper at this time.
Design
Review
This paper reviews the current status and future directions of cardiovascular biomarkers.
Cardiovascular disease (CVD) remains a global health concern of paramount significance, claiming millions of lives each year [...].
No takes yet. Share an insight, caveat, or question.
Filipovic et al. (2023) studied this question. Cardiovascular biomarkers require ongoing evaluation and future development to better address the significant global health burden and mortality of cardiovascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: